Attached files
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
I,
Tannya L. Irizarry, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that the Quarterly Report on Form 10-Q of GeneThera, Inc. for the
quarterly period ended March 31, 2018, fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange
Act of 1934 and that the information contained in the Quarterly
Report on Form 10-Q fairly presents in all material respects the
financial condition and results of operations of GeneThera,
Inc.
By: /s/
Tannya L Irizarry
Name:
Tannya L Irizarry
Title:
Chief Financial Officer (Interim) (Principal Financial/Accounting
Officer)
Date:
November 30, 2018